Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines
Blood
; 138:3891, 2021.
Article
in English
| EMBASE | ID: covidwho-1582255
CD19, antigen; CD4, antigen; endogenous, compound; human, immunoglobulin; immunoglobulin, G; immunoglobulin, G, antibody; meprobamate; messenger, RNA; neutralizing, antibody; phytohemagglutinin; RNA, vaccine; SARS-CoV-2, vaccine; adult; advisory, committee; B, lymphocyte; biomedicine; CD4+, T, lymphocyte; cell, count; cell, therapy; cohort, analysis; conference, abstract; controlled, study; drug, therapy; female; funding; gender; gene, expression; human; human, tissue; immune, reconstitution; immune, response; immune, status; immunoglobulin, blood, level; major, clinical, study; male; nonhuman; prospective, study; protein, expression; Severe, acute, respiratory, syndrome, coronavirus, 2; spike; vaccination
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Blood
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS